Skip to main content

Table 2 Sex differences in metabolic effects of the RAS in clinical opulations

From: Sex differences in the metabolic effects of the renin-angiotensin system

RAS component

Obesity

Dyslipidemia

Insulin sensitivity

Glucose tolerance

References

Angiotensinogen

 Males

UNK

UNK

↓

UNK

[100]

 Females

↑

↑

↓

UNK

[100,101,102]

Renin

 Males

↑

UNK

↓

↓

[103]

 Females

↓, ↑

UNK

↓

↓

[103]

Prorenin

 Males

UNK

UNK

UNK

UNK

 

 Females

UNK

UNK

UNK

UNK

 

Angiotensin II

 Males

↑

↑

↓

↓

[104,105,106]

 Females

↑

↑

↓

↓

[104, 107]

ACE

 Males

-

↑

↓

↓

[108,109,110]

 Females

-

↑

↓

↓

[101, 108, 110]

AT1 receptors

 Males

-

↑

↓

↓

[103, 105, 110,111,112,113]

 Females

-

↑

↓

↓

[103, 105, 110, 112, 113]

AT2 receptors

 Males

UNK

UNK

UNK

UNK

 

 Females

↓

UNK

↑

↑

[114, 115]

Angiotensin-(1-7)

 Males

UNK

UNK

UNK

UNK

 

 Females

UNK

UNK

UNK

UNK

 

ACE2

 Males

UNK

UNK

UNK

UNK

 

 Females

UNK

UNK

UNK

UNK

 

Mas receptors

 Males

↑

UNK

UNK

UNK

[116]

 Females

↑

UNK

UNK

UNK

[116]

Alamandine

 Males

UNK

UNK

UNK

UNK

 

 Females

UNK

UNK

UNK

UNK

 
  1. ACE angiotensin-converting enzyme, ACE2 angiotensin-converting enzyme 2, AT1 angiotensin II type 1, AT2 angiotensin II type 2, RAS renin-angiotensin system, ↑ increases, ↓ decreases, - neutral effects, UNK information currently unknown